United States · FDA National Drug Code directory
AQNEURSA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83853-101_49d32782-3faa-4670-99bf-db9b7115f2d0
- Product NDC
- 83853-101
- Form
- GRANULE, FOR SUSPENSION
- Composition / generic term
- levacetylleucine
- Labeler
- IntraBio Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240924
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVACETYLLEUCINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 PACKET in 1 CARTON (83853-101-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET · 83853-101-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →